Thousands of men with advanced prostate cancer in England are set to benefit from a life-extending drug that can be taken at ...

A drug that kills cancer cells by puncturing them comes with an additional benefit: tests in mice suggest it reduces the growth of pain-sensing nerves around tumours ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: Many men’s health issues are either entirely preventable ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.

For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its ...

The second annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) documents a ...